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Summary
The Salmonella type III effector, SopB, is an inositol
polyphosphate phosphatase that modulates host
cell phospholipids at the plasma membrane and
the nascent Salmonella-containing vacuole (SCV).
Translocated SopB persists for many hours after
infectionandisubiquitinatedbutthesigniﬁcanceof
this covalent modiﬁcation has not been investi-
gated. Here we identify by mass spectrometry
six lysine residues of SopB that are mono-
ubiquitinated. Substitution of these six lysine resi-
dues with arginine, SopB-K6R, almost completely
eliminated SopB ubiquitination. We found that
ubiquitination does not affect SopB stability or
membrane association, or SopB-dependent events
in SCV biogenesis. However, two spatially and tem-
porallydistincteventsaredependentonubiquitina-
tion, downregulation of SopB activity at the plasma
membrane and prolonged retention of SopB on the
SCV. Activation of the mammalian pro-survival
kinase Akt/PKB, a downstream target of SopB, was
intensiﬁed and prolonged after infection with the
SopB-K6R mutant. At later times, fewer SCV were
decorated with SopB-K6R compared with SopB.
Instead SopB-K6R was present as discrete vesicles
spreaddiffuselythroughoutthecell.Altogether,our
data show that ubiquitination of SopB is not related
to its intracellular stability but rather regulates its
enzymatic activity at the plasma membrane and
intracellular localization.
Introduction
Post-translational modiﬁcation by ubiquitin, or the
ubiquitin-like (Ubl) proteins, is an important mechanism
for regulating a broad range of biological processes.
Ubiquitin is a small globular protein that is covalently
attached to target proteins, most commonly at lysine resi-
dues. Ubiquitin itself contains seven lysine residues,
allowing it to serve as a substrate for poly-ubiquitin chain
formation. Similar to other post-translational modiﬁcations
such as phosphorylation, ubiquitination is a dynamic,
reversible process. The covalent attachment of ubiquitin
to target proteins is catalysed in a three-step enzymatic
cascade involving ubiquitin-activating (E1) and ubiquitin-
conjugating (E2) enzymes and ubiquitin ligases (E3). The
removal of ubiquitin occurs in one step, catalysed by
deubiquitinases (Kerscher et al., 2006). Historically, the
post-translational modiﬁcation of proteins by ubiquitin
has been associated with protein degradation (Mukho-
padhyay and Riezman, 2007). Poly-ubiquitin chains of at
least four Lys48-linked ubiquitin molecules efficiently
target a protein for destruction by the 26S proteasome.
More recently, non-proteolytic functions of ubiquitination
have been revealed in many cellular pathways including
membrane trafficking, DNA repair and replication and
gene transcription (Welchman et al., 2005; Mukho-
padhyay and Riezman, 2007; Chen and Sun, 2009). The
Ubl proteins, a family of proteins related to ubiquitin, can
also be covalently attached to lysine side-chains in target
proteins and modify their function. Examples of Ubl
proteins include interferon-stimulated gene-15 (ISG15),
neural precursor cell-expressed developmentally
downregulated-8 (NEDD8), small ubiquitin-related modi-
ﬁer (SUMO) and Atg8 (Welchman et al., 2005; Kerscher
et al., 2006).
The ability of a pathogen to cause disease results from
its being able to successfully compete at the host–
pathogen interface. During the course of co-evolution,
viral and bacterial pathogens have developed many strat-
egies to manipulate host cells to their own advantage.
Given the signiﬁcance of ubiquitin and Ubl proteins to
regulating mammalian cell processes, it is perhaps not
surprising that many pathogens have targeted ubiquitin
and Ubl conjugation pathways. For example, pathogens
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cellular microbiologycan regulate the host immune response by interfering with
ubiquitin and Ubl protein-associated enzymes (Angot
et al., 2007; Edelmann and Kessler, 2008). Alternatively,
some pathogens encode virulence factors that are struc-
tural mimics of E3 ubiquitin ligases and deubiquitinases
(Angot et al., 2007; Edelmann and Kessler, 2008).
Viruses, protozoan and bacterial pathogens have all
developed mechanisms to target these processes but this
appears especially prevalent for Gram-negative bacteria
that inject their own proteins, known as effectors, into host
cells using type III (T3SS) or type IV secretion systems.
The functions of virulence proteins can also be modiﬁed
by ubiquitin or Ubl protein conjugation. For instance, the
activity of some bacterial toxins and type III effectors is
downregulated by poly-ubiquitin conjugation and protea-
somal degradation, including listeriolysin O from Listeria
monocytogenes (Schnupf et al., 2006), SopE and
SopA from Salmonella enterica serovar Typhimurium
(S. Typhimurium) (Kubori and Galan, 2003; Zhang et al.,
2005), YopE from Yersinia enterocolitica (Ruckdeschel
et al., 2006) and ExoT from Pseudomonas aeruginosa
(Balachandran et al., 2007). Another two virulence pro-
teins, SopB from S. Typhimurium (Marcus et al., 2001)
and ExoU from P. aeruginosa (Stirling et al., 2006), are
ubiquitinated, but this modiﬁcation does not serve as a
signal for proteasomal degradation. All of these examples
exemplify two points; that the ubiquitin machinery is
important to pathogenic virulence and the degree of
cross-talk between pathogen and host at the level of
ubiquitin and Ubl proteins is extensive.
The Salmonella type III effector, SopB, is an inositol
phosphatase that acts on host cell membrane phospho-
lipids. Its biological activity affects several facets of the
interaction between Salmonella and mammalian cells. For
example, its actions are required for optimal bacterial
entry into non-phagocytic cells (Raffatellu et al., 2005),
activation of the mammalian pro-survival kinase Akt/PKB
(Steele-Mortimer et al., 2000) and maturation of the
Salmonella-containing vacuole (SCV), by generating
phosphatidylinositol (PI) 3-phosphate (PI(3)P) on the SCV
and recruiting lysosomal glycoproteins to the SCV (Her-
nandez et al., 2004). It has previously been shown that
SopB is membrane-associated and ubiquitinated after
translocation into epithelial cells (Marcus et al., 2002).
One unusual aspect of SopB activity is that it can be
detected for several hours post invasion (Marcus et al.,
2002; Drecktrah et al., 2005; Wasylnka et al., 2008), in
contrast to most other ‘invasion-associated’ Salmonella
effector proteins that are active for only a short time
during, and immediately following, the invasion process.
For example, the ubiquitin-dependent proteolysis of SopE
is crucial for the rapid downregulation of actin-based
plasma membrane ruffling following internalization of Sal-
monella into epithelial cells (Kubori and Galan, 2003). The
longevity of translocated SopB, in comparison, suggests
that ubiquitination plays a different role in the regulation of
this type III effector.
In order to clarify why SopB is post-translationally modi-
ﬁed, we ﬁrst determined which residues of SopB are ubi-
quitinated by mass spectrometry. We identiﬁed six lysine
residues of SopB as ubiquitin conjugation sites. Speciﬁc
mutation of these residues allowed us to test the function
of ubiquitination and indicated that this post-translational
modiﬁcation regulates SopB activity without affecting its
turnover.
Results
Translocation and ubiquitination of SopB continues for
many hours post infection
Post-translational modiﬁcation of eukaryotic proteins by
ubiquitin or Ubl modiﬁers is an important process by which
the stability, localization or activity of intracellular proteins
can be controlled (Kerscher et al., 2006). Recently,
ubiquitination of several pathogenic proteins, including
the Salmonella effector protein SopB (Marcus et al.,
2002), has been demonstrated. To investigate this
process in more detail, we ﬁrst asked whether SopB is
also a substrate for conjugation by the Ubl modiﬁers
ISG15, NEDD8 or SUMO1. HeLa cells expressing
haemagglutinin (HA)-tagged forms of the modiﬁers were
infected with Salmonella for 2 h, to allow for maximal
translocation of SopB. Then total SopB, incorporating the
intrabacterial pool as well as translocated protein, was
immunoprecipitated from lysates and analysed by
immunoblotting. Whole cell lysates were probed with
anti-HA antibodies to detect ectopic expression levels.
HA-SUMO and HA-ubiquitin were incorporated into mul-
tiple high-molecular-weight proteins, whereas HA-ISG15
and HA-NEDD8 monomers were primarily detected, at 18
and 6 kDa respectively (Fig. 1A and not shown). This is in
agreement with the known prevalence of SUMO and
ubiquitin substrates compared with ISG15 and NEDD8
(Kamitani et al., 1997; Welchman et al., 2005). When the
immunoprecipitates were probed with an anti-SopB anti-
body, three SopB bands were detected in all of the
lysates, migrating at ~60, ~68 and ~75 kDa (Fig. 1A).
By contrast, anti-HA antibodies only detected proteins
in co-immunoprecipitates from cells expressing HA-
ubiquitin, indicating that SopB is not modiﬁed by ISG15,
NEDD8 or SUMO1. In the HA-ubiquitin sample, two
distinct bands at ~68 kDa and ~75 kDa, and a slower
migrating smear > 85 kDa were clearly resolved. These
presumably represent mono-, di- and poly-ubiquitinated
species of SopB respectively. We conclude from these
immunoprecipitation experiments that ubiquitin, but not
Ubl modiﬁers, targets SopB in infected cells.
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during Salmonella infection of epithelial cells. In order to
differentiate between the two intracellular pools of SopB;
(i) translocated and (ii) intrabacterial, we used a recently
described methodology based upon a 13-amino-acid tag
derived from glycogen synthase kinase 3b (GSK) (Garcia
et al., 2006). Because this tag is phosphorylated by serine
protein kinases in mammalian cells, but not in bacteria, it
can be used in conjunction with phospho-speciﬁc anti-
bodies as a reporter for translocation. For these experi-
ments bacteria lacking both SopB and its chaperone
SigE (DsopB-sigE) were complemented with a low
Fig. 1. Translocated SopB is modiﬁed by ubiquitin, but not ubiquitin-like proteins.
A. SopB is not modiﬁed by ISG15, NEDD8 or SUMO1. HeLa cells were transfected with HA-ISG15, HA-NEDD8, HA-SUMO1 or HA-ubiquitin
(Ub) for 18 h prior to infection with DsopB-sigE Salmonella expressing plasmid-borne SopB and SigE under the control of the sopB promoter
(pWSKDE). At 2 h p.i., cells were solubilized on ice for 15 min, then post-nuclear supernatants were incubated with rabbit polyclonal anti-SopB
antibodies followed by Protein A Sepharose beads. Bound proteins were eluted with boiling 1.5¥ SDS-PAGE sample buffer, separated by
SDS-PAGE and subject to immunoblotting with mouse polyclonal anti-SopB antibodies and mouse monoclonal anti-HA antibodies. Whole cell
lysates were also probed with mouse anti-HA antibodies (bottom panel). Molecular mass markers in kDa are indicated on the left of each
panel.
B. Ubiquitinated SopB accumulates with time. HeLa cells were infected with DsopB-sigE Salmonella complemented with plasmid-borne
SopB fused to a phosphorylatable tag derived from GSK, and its cognate type III chaperone, SigE (pWSKDE-GSK). At the indicated times,
monolayers were solubilized, proteins were separated by SDS-PAGE and subject to immunoblotting with antibodies directed against
phospho-Ser9-GSK 3b (to detect translocated SopB-GSK), GSK tag (total SopB-GSK), phospho-Ser473-Akt (activated Akt) and Akt pan
(total Akt). Where indicated, 10 mgm l
-1 tetracycline (+ Tet) was added at 30 min p.i. to stop bacterial protein synthesis.
C. Taqman
® quantitative PCR analysis of sopB and ssaH transcript levels. HeLa cells were infected with wild-type Salmonella and samples
were processed for quantitative PCR. To stop bacterial transcription after internalization, 5 mgm l
-1 rifampicin was added at 10 min p.i. sopB
and ssaH transcripts are normalized to ftsZ transcript amounts. Each symbol represents the mean from one experiment. The lines represent
the statistical mean from four independent experiments. Closed circles, untreated. Open circles, rifampicin-treated cells.
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(pWSKDE-GSK), expressed under the control of the sopB
transcriptional promoter. Lysates prepared from infected
HeLa cells at 0.5–6 h post infection (p.i.) were subject to
immunoblot analysis using phospho-speciﬁc anti-GSK
antibodies to detect translocated SopB-GSK. Three
bands were revealed; one migrating at the predicted
molecular mass of unmodiﬁed SopB (60 kDa), and
two slower migrating species representing mono- and
di-ubiquitinated SopB (Fig. 1B). While all three bands
accumulated with time, indicating that both translocation
and ubiquitination of SopB continued for several hours
following infection, amounts of unmodiﬁed SopB always
exceeded the ubiquitinated forms. It is important to note
that SopB is translocated to the plasma membrane upon
initial contact with host cells and after bacterial internal-
ization to the SCV, therefore this proﬁle represents a
mixture of translocated SopB in these two spatially sepa-
rate locales. Antibodies that recognize total GSK showed
a similar increase in SopB-GSK with time, although the
proportion of unmodiﬁed SopB (60 kDa) was more promi-
nent than for the translocated SopB proﬁle, suggesting
that a signiﬁcant proportion of SopB remains intrabacte-
rial. To ensure that the GSK-tagged SopB was biologically
active, we assessed the levels of phosphorylated Akt
(phospho-Ser473 antibodies) in the lysates because
SopB induces the phosphorylation of this eukaryotic
kinase in epithelial cells (Steele-Mortimer et al., 2000;
Knodler et al., 2005). Akt phosphorylation kinetics were
similar to that shown previously, with a peak at 0.5–1 h p.i.
(Knodler et al., 2005), but interestingly this was not
coincident with maximal levels of translocated SopB
( 4 h p.i.).
The prolonged accumulation of translocated SopB is
unexpected for a type III effector that is part of the Sal-
monella pathogenicity island 1 regulon. We used real-time
PCR to study the levels of sopB transcription after bacte-
rial internalization. HeLa cells were infected with wild-type
bacteria and samples were processed for quantitative
real-time PCR analysis at various times p.i. To prevent
bacterial transcription after internalization, rifampicin was
added at 10 min p.i. Transcript levels of sopB and ssaH,a
gene encoding a structural component of T3SS2, were
compared in the absence and presence of rifampicin over
the time-course (Fig. 1C). Similar to phagocytic cells, the
expression of sopB rapidly decreased after bacterial inter-
nalization (Drecktrah et al., 2006). However, sopB tran-
script levels were higher in untreated cells than for
rifampicin-treated cells up to 6 h p.i. By comparison, the
T3SS2 apparatus gene ssaH was induced intracellularly,
in agreement with previous data from phagocytic cells
(Cirillo et al., 1998; Drecktrah et al., 2006). Rifampicin
treatment effectively diminished this intracellular induc-
tion, conﬁrming that bacterial transcription was effectively
prevented. From these data we conclude that, despite a
net downregulation of sopB after internalization, bacteria
continue to transcribe this gene up to 6 h p.i. Next we
examined whether the accumulation of translocated SopB
with time also requires protein synthesis after internaliza-
tion. HeLa cells were infected with DsopB-sigE bacteria
complemented with pWSKDE-GSK and treated with
tetracycline at 30 min p.i. to block bacterial protein syn-
thesis. Whole cell lysates were then subject to immuno-
blot analysis for phospho-GSK (translocated SopB) and
GSK tag (total SopB) (Fig. 1B). Tetracycline treatment
effectively prevented the accumulation of all forms of
SopB, demonstrating that de novo protein synthesis is
required for the prolonged accumulation of SopB in host
cells. We conclude from these experiments that sopB
continues to be transcribed and translated for many hours
after bacterial internalization.
Six lysine residues of SopB serve as ubiquitin
acceptor sites
To further characterize the ubiquitination of SopB we used
mass spectrometry analysis to identify conjugated lysine
residues. As SopB contains 50 lysine residues that are
potential ubiquitin conjugation sites, mutational analysis
would not be practical. As an alternative, HeLa cells were
transfected with a plasmid encoding Myc-tagged SopB
(pCMV-Myc-SopB) and the protein puriﬁed by immuno-
precipitation using an anti-Myc antibody, in order to obtain
sufficient material for analysis. We have previously shown
that, like translocated SopB, ectopically expressed SopB
is ubiquitinated in mammalian cells (Marcus et al., 2002).
Immunopuriﬁed SopB was separated by SDS-PAGE,
visualized by GelCode Blue staining (Fig. 2A) and the
regions containing unmodiﬁed SopB and ubiquitinated
SopB (SopB-Ub) were excised, digested with trypsin and
analysed by capillary liquid chromatography tandem
mass spectrometry. Trypsin digestion of ubiquitinated pro-
teins produces unique signature peptides which can be
identiﬁed by their additional mass of 114.043 Da, corre-
sponding to the –GG remnant from ubiquitin that remains
conjugated to lysine residues (Xu and Peng, 2006). The
Ubl proteins, NEDD8 and ISG15, also produce the same
–GG signature tag when cleaved by trypsin. Modiﬁcation
by ubiquitin and Ubl proteins also causes a missed trypsin
cleavage at the modiﬁed lysine residue (Xu and Peng,
2006).As we had already shown that SopB is not modiﬁed
by either NEDD8 or ISG15 (Fig. 1A), any lysine modiﬁca-
tion would be due to ubiquitin conjugation only. Mass
spectrometry analysis revealed no –GG signature pep-
tides in the sample containing unmodiﬁed SopB, with
peptide coverage of ~80% of the SopB sequence. By
contrast, six ubiquitination sites were identiﬁed for SopB-
Ub; Lys13, Lys19, Lys23, Lys37, Lys41 and Lys541
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SopB sequence. The identiﬁcation of multiple modiﬁcation
sites, together with a single SopB-Ub band on SDS-PAGE
gels, suggests that SopB is mono-ubiquitinated on any
one of six lysine residues at once, but not all six residues
simultaneously. Interestingly, ﬁve of the identiﬁed lysines
are clustered at the N-terminus of SopB (Fig. 2C, black
arrowheads).
In order to characterize the requirement for these six
lysines in SopB ubiquitination, site-directed mutagenesis
was used to create lysine-to-arginine substitutions in the
pCMV-Myc-SopB plasmid. Following ectopic expression
in transfected HeLa cells, the level of post-translational
modiﬁcation was monitored by immunoblotting of whole
cell lysates with anti-SopB antibodies. Ectopically
expressed SopB appeared as two bands in immunoblots,
representing unmodiﬁed and mono-ubiquitinated SopB
(Fig. 2D) (Marcus et al., 2002). Single lysine-to-arginine
substitutions had no detectable effect on the ubiquitina-
tion status of SopB (results not shown), indicating that no
single lysine residue is essential or preferred as a conju-
gation site. However, ubiquitination of a SopB mutant in
which all six lysine residues were substituted (SopB-K6R)
was substantially decreased (Fig. 2D). The residual ubi-
quitination presumably occurs on one or more additional
residues that were not identiﬁed by mass spectrometry.
Having shown that ectopically expressed SopB can be
mono-ubiquitinated on at least six different lysine resi-
dues, we next assessed whether this is also true after
bacterial translocation of SopB. Site-directed muta-
genesis was used to create lysine-to-arginine substitu-
tions at all six residues in plasmid borne SopB. The
resultant plasmid, pWSKDE-K6R, was then used to com-
plement the DsopB-sigE mutant. HeLa cells expressing
HA-ubiquitin were infected with either DsopB-sigE
pWSKDE or DsopB-sigE pWSKDE-K6R bacteria. At 2 h
p.i., monolayers were lysed and subject to immunopre-
cipitation with anti-SopB antibodies. Immunoprecipitates
Fig. 2. Identiﬁcation of six lysine residues as ubiquitin conjugation sites.
A. Immunopuriﬁcation of SopB. HeLa cells ectopically expressing Myc-SopB were lysed and post-nuclear supernatants were incubated with
anti-Myc monoclonal antibodies followed by Protein A Sepharose. Bound proteins were separated by SDS-PAGE and visualized using
GelCode Blue reagent. Bands corresponding to unmodiﬁed SopB (SopB) and ubiquitinated SopB (SopB-Ub) were excised and subject to
mass spectrometric analysis. HC, heavy chain; LC, light chain.
B. Six ubiquitin-conjugated tryptic peptides were identiﬁed by mass spectrometry. Asterisks indicate the ubiquitinated lysine residues. Periods
indicate the sites of trypsin cleavage.
C. Schematic of SopB. Arrowheads indicate the 50 lysine residues present in SopB. Black arrowheads denote the six lysines that were
identiﬁed as ubiquitin conjugation sites. Black boxes and a grey box represent regions with homology to mammalian 4′-phosphatases and
5′-phosphatases respectively. The hatched box depicts a predicted coiled-coil domain.
D. Mutation of the six identiﬁed lysine residues impairs ubiquitination of transfected SopB. Left panel: HeLa cells were untreated (–) or
transiently transfected for 18 h with Myc-SopB (SopB) or Myc-SopB K13R K19R K23R K37R K41R K541R (SopB-K
6R). Monolayers were
lysed in boiling 1.5¥ SDS-PAGE sample buffer, proteins separated by SDS-PAGE and subject to immunoblotting with mouse polyclonal
anti-SopB antibodies. Right panel: Densitometric analysis of unmodiﬁed and monoubiquitinated SopB bands was used to determine the
amount of SopB that was modiﬁed. Results are means  SD from three separate experiments. P < 0.001, Student’s t-test.
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and HA (Fig. 3A). Immunoprecipitated SopB migrated as
three distinct bands on SDS-PAGE, representing the
unmodiﬁed, mono- and di-ubiquitinated forms of SopB. By
contrast, SopB-K6R migrated as a single species at
60 kDa, the same molecular mass as unmodiﬁed SopB.
Furthermore, co-immunoprecipitation of HA-ubiquitin was
almost completely eliminated for SopB-K6R, compared
with wild-type SopB. Collectively, these data demonstrate
that multiple lysines in SopB can be mono-ubiquitinated,
and mutation of all these lysine residues (K13R, K19R,
K23R, K37R, K41R, K541R) impairs ubiquitination of
translocated SopB.
Ubiquitination does not affect SopB stability or
membrane association
We next evaluated the role of SopB ubiquitination on
protein stability and localization, two known functions of
this post-translational modiﬁcation. To monitor the stability
of translocated SopB, a modiﬁed pulse-chase experiment
was used. HeLa cells were infected with DsopB-sigE
bacteria complemented with either pWSKDE-GSK or
pWSKDE-K6R-GSK. At 2 h p.i., tetracycline was added to
stop bacterial protein synthesis. Samples were then taken
at hourly intervals and whole cell lysates subject to
immunoblotting with phospho-GSK antibodies to detect
translocated SopB (Fig. 3B). After the addition of anti-
biotic, there was a steady decline in the amount of SopB,
ubiquitinated SopB and SopB-K6R with time. Densito-
metric analysis showed that all three species had a half-
life of approximately 2 h after translocation into the host
cell. We conclude from these results that ubiquitination
does not inﬂuence the degradation rate of SopB.
We have previously shown that SopB is targeted to host
cell membranes after bacterial translocation (Marcus
et al., 2002). We therefore considered whether ubiquitin
affects the intracellular targeting of SopB. Epithelial cells
were infected with DsopB-sigE bacteria complemented
with either pWSKDE-GSK or pWSKDE-K6R-GSK and at
Fig. 3. Ubiquitination of SopB does not alter its stability.
A. Translocated SopB-K
6R is defective for ubiquitination. HeLa cells expressing HA-ubiquitin were infected with DsopB-sigE Salmonella
expressing plasmid-borne SopB (SopB) and SigE, or SopB with six lysine mutations (SopB-K
6R) and SigE. At 2 h p.i., cells were solubilized
and post-nuclear supernatants incubated with rabbit polyclonal anti-SopB antibodies followed by Protein A Sepharose beads. Bound proteins
were eluted, separated by SDS-PAGE and subject to immunoblotting with mouse polyclonal anti-SopB antibodies or mouse monoclonal
anti-HA antibodies. Whole cell lysates were also probed with anti-HA antibodies.
B. Ubiquitination does not affect the stability of translocated SopB. HeLa cells were infected with DsopB-sigE Salmonella harbouring
pWSKDE-GSK or pWSKDE-K
6R-GSK. At 2 h p.i., 10 mgm l
-1 tetracycline was added to the infected monolayers to stop bacterial protein
synthesis and whole cell lysates were collected at hourly intervals by adding boiling 1.5¥ SDS-PAGE sample buffer. The stability of
translocated SopB-GSK was monitored by immunoblotting with rabbit polyclonal antibodies against phospho-GSK. Graph shows densitometric
analysis from three separate experiments (mean  SD).
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tial centrifugation at 1000 g, 6000 g and 100 000 g result-
ing in four fractions; P1K (nuclei), P6K (bacteria and
nuclei), P100K (HeLa cell membranes), S100K (HeLa cell
cytosol). The content of these fractions was assessed by
immunoblotting with antibodies to the following proteins:
lamin A/C, lysosomal-associated membrane protein 1
(LAMP1), Hsp27, DnaK, phospho-GSK (translocated
SopB-GSK) and GSK-tag (total SopB-GSK) (Fig. 4A). The
nuclear marker, lamin A/C, was equally detected in P1K
and P6K fractions whereas DnaK, a marker for intact
bacteria, was enriched in the P6K fraction, with only a
small amount detected in P1K. No bacterial contamination
(DnaK) was detected in the P100K or S100K fractions,
which contained the host cell membrane and cytosolic
proteins, LAMP1 and Hsp27 respectively. The three major
forms of translocated SopB (60, 68 and 75 kDa) were
primarily detected in the P100K fraction. The 60 kDa
unmodiﬁed SopB and the 68 kDa mono-ubiquitinated
SopB were also detected to a lesser extent in the P1K and
P6K fractions. Importantly, all forms of SopB, including
SopB-K6R, partitioned similarly. From these subcellular
fractionation experiments we conclude that translocated
SopB is enriched in host cell membrane fractions inde-
pendent of its ubiquitination status.
We next asked whether ubiquitination of SopB could
change the nature of its association with host cell mem-
branes. Host cell membrane fractions were prepared from
infected HeLa cells at 1.5 h p.i. as described above and
then treated with either high salt, sodium carbonate or
Triton X-100 (TX-100) on ice for 30 min. Subsequently,
the samples were ultracentrifuged and equivalent
volumes of soluble and insoluble fractions analysed
by immunoblotting with antibodies against calnexin,
calreticulin and phospho-GSK (Fig. 4B). Treatment of
membranes with high salt or sodium carbonate pH 11.5
releases peripheral membrane proteins that are associ-
ated by ionic or hydrophobic interactions respectively,
whereas integral membrane proteins are only solubilized
by detergents (Helenius and Simons, 1975; Fujiki et al.,
1982). Conﬁrming this, the peripheral membrane protein,
calreticulin, was extracted from membranes with sodium
carbonate and TX-100, whereas the integral membrane
protein, calnexin, was solubilized by detergent treatment
only. Translocated SopB was removed from membranes
with sodium carbonate and TX-100 treatments, but not
Fig. 4. Membrane association of SopB is independent of ubiquitination.
A. Translocated SopB and SopB-K
6R fractionate to host cell membranes. HeLa cells were infected with Salmonella as described for Fig. 3A.
At 1.5 h p.i., cells were mechanically fractionated and subject to differential centrifugation to obtain four fractions – P1K, P6K, P100K and
S100K. Equal volumes were separated by SDS-PAGE and subject to immunoblotting with antibodies directed against phospho-GSK
(translocated SopB), GSK tag (total SopB), lamin A/C (nucleus), DnaK (intact bacteria), LAMP1 (HeLa membranes) and Hsp27 (HeLa cytosol).
B. Membrane association of translocated SopB and SopB-K
6R is via hydrophobic interactions. HeLa cells were infected with Salmonella as
described in Fig. 3A. At 1.5 h p.i., cells were mechanically fractionated and host cell membranes puriﬁed by ultracentrifugation. Membranes
were extracted on ice with phosphate-buffered saline (PBS), high salt (1 M NaCl), sodium carbonate pH 11.5 (Na2CO3) or non-ionic detergent
(TX-100). Insoluble (P) and soluble (S) fractions were then separated by ultracentrifugation. Equal volumes were subject to immunoblotting
with antibodies against phospho-GSK (translocated SopB), calreticulin (peripheral membrane protein) or calnexin (integral membrane protein).
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for ectopically expressed SopB (Marcus et al., 2002).
There was no reproducible difference in the degree of
solubilization of SopB, ubiquitinated SopB or SopB-K6R
with the four treatments. Therefore, translocated SopB is
peripherally associated with membranes by hydrophobic
interactions, regardless of its ubiquitination.
The association of SopB with the SCV is inﬂuenced by
its ubiquitination
One possibility is that ubiquitin-defective SopB remains
associated with host cell membranes but has an altered
intracellular location, so we compared the intracellular
localization of SopB and SopB-K6R after translocation.
HeLa cells were infected with DsopB-sigE bacteria
complemented with HA-tagged SopB or SopB-K6R. At
various times p.i., cells were ﬁxed and immunostained with
anti-HA antibodies to detect translocated SopB and anti-
Salmonella lipopolysaccharide (LPS) antibodies. At early
times p.i., most of the infected cells were positive for
translocated SopB-2HA or SopB-K6R-2HA. With time, we
observed an overall decrease in the number of infected
cells positive for translocated SopB and SopB-K6R
(Fig. 5A).Translocated SopB and SopB-K6R was detected
as early as 15 min p.i., present in a patchy distribution on
the SCV surrounding the bacteria (Fig. 5C), similar to what
we have previously described (Marcus et al., 2002). Com-
paratively fewer SopB-K6R bacteria were positive for SCV
staining at 15 min p.i. and the peak of SCV association
was at 30 min p.i. for both SopB and SopB-K6R (Fig. 5B).
While the immunostaining pattern for SopB and SopB-K6R
was indistinguishable at early times p.i. ( 2 h p.i.), at later
times, SopB-2HA remained associated with the SCV and
was also detected in small vesicles in the vicinity of the
SCV, whereas SopB-K6R-2HA was primarily detected as
small punctate structures spread throughout the cell,
appearing to have diffused away from SCVs (Fig. 5C). As
a result, there was a signiﬁcant difference in the number of
SCVs decorated with SopB-2HA and SopB-K6R-2HA at 4
and 6 h p.i. (Fig. 5B). From these observations, we con-
clude that ubiquitination of SopB leads to its prolonged
retention on the SCV.
SopB-dependent SCV trafficking events are
independent of its ubiquitination
The biological activity of SopB contributes to several
aspects of vacuole trafficking, including SCV maturation
and positioning (Hernandez et al., 2004; Mallo et al.,
2008; Wasylnka et al., 2008). To investigate if the
ubiquitination of SopB plays a role in SCV biogenesis,
we studied generation of the phospholipid, PI(3)P, and
recruitment of the lysosomal glycoprotein, LAMP1, two
processes that are affected by SopB. PI(3)P accumu-
lates on the outer leaﬂet of SCVs immediately after bac-
terial entry, whereas LAMP1 is more gradually recruited
to the SCV (Steele-Mortimer et al., 1999; Pattni et al.,
2001; Hernandez et al., 2004). The double FYVE ﬁnger
from Hrs was used as a speciﬁc probe for PI(3)P (Pattni
et al., 2001). HeLa cells expressing a 2xFYVE-enhanced
green ﬂuorescent protein (EGFP) fusion were infected
with Salmonella and at various times p.i. monolayers
were ﬁxed and immunostained with anti-Salmonella LPS
antibodies to discriminate intracellular bacteria (Fig. 6A).
For wild-type Salmonella, the peak of PI(3)P accumula-
tion on SCVs was at 15 min p.i., and thereafter steadily
declined. Markedly fewer SCVs containing DsopB-sigE
bacteria were positive for the 2xFYVE probe at 15 min
p.i., in agreement with previous reports (Mallo et al.,
2008), but there was no signiﬁcant difference in PI(3)P
labelling of wild type and DsopB vacuoles at times
 30 min p.i. Interestingly, a similar proﬁle of early SopB-
dependent, and later SopB-independent, Rab5 recruit-
ment to the SCV has been reported (Mallo et al., 2008).
Complementation of the DsopB-sigE mutant with wild-
type SopB or SopB-K6R gave indistinguishable results
from wild-type bacteria, demonstrating that SopB ubi-
quitination does not inﬂuence PI(3)P generation on the
SCV.
A sopB mutant is delayed for SCV maturation, as
assessed by the recruitment of lysosomal membrane gly-
coproteins such as LAMP1 (Hernandez et al., 2004). To
determine if SopB ubiquitination affected this aspect of
SCV trafficking, HeLa cells were infected with Salmonella
and at various times p.i., monolayers were ﬁxed and
immunostained with antibodies against Salmonella LPS
and LAMP1. We also found that SopB is required for
efficient LAMP1 acquisition, but only at times < 1 h p.i.
(Fig. 6B). Our complementation data showed that the
ubiquitination of SopB does not contribute to vacuole
maturation, because there was no difference in the kine-
tics of LAMP1 recruitment for SCVs containing bacteria
expressing wild-type SopB or SopB-K6R. We conclude
that the early SopB-dependent SCV trafficking events
(< 1 h p.i.) are not inﬂuenced by the post-translational
modiﬁcation of SopB. This is consistent with the time-
course of SopB ubiquitination, which is not evident until
 1 h p.i. (Fig. 1B).
Ubiquitination affects SopB activity at the plasma
membrane
We have previously described the Salmonella-induced
activation of the mammalian pro-survival kinase, Akt/PKB
(Steele-Mortimer et al., 2000). Unlike SCV trafficking
events, phosphorylation of Akt in infected cells is
absolutely dependent on SopB. To investigate whether
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A. Ubiquitination does not affect the incidence of SopB translocation. HeLa cells were infected with DsopB-sigE bacteria complemented with
plasmid-borne SopB-2HA and SigE (pWSKDE-2HA), or SopB-K
6R-2HA and SigE (pWSKDE-K
6R-2HA). At various times p.i., monolayers were
ﬁxed and immunostained with antibodies against the HA-epitope tag and Salmonella LPS. The number of infected cells that were positive for
SopB-2HA or SopB-K
6R-2HA staining was scored visually by ﬂuorescence microscopy. Mean  SD (n > 150 infected cells per time point).
Closed circles, SopB-2HA; open circles, SopB-K
6R-2HA.
B. Ubiquitination increases the association of SopB with the SCV. HeLa cells were infected and immunostained as for (A). For SopB-positive
infected cells, the number of bacteria that were surrounded by SopB-2HA or SopB-K
6R-2HA was scored. Mean  SD from three separate
experiments (> 300 bacteria per time point). Closed circles, SopB-2HA; open circles, SopB-K
6R-2HA. Asterisks denote signiﬁcantly different
from wild-type SopB (P < 0.05, Student’s t-test).
C. Representative confocal microscopy images of translocated SopB-2HA and SopB-K
6R-2HA at 1 h and 4 h p.i. At 1 h p.i., both SopB and
SopB-K
6R show ‘patchy’ staining around the bacteria, on the SCV. By 4 h p.i., there is less association of SopB and SopB-K
6R with the SCV
and SopB-K
6R is primarily seen as punctate structures spread diffusely throughout the cell. Inset shows three times enlargement of indicated
area. Scale bar is 10 mM.
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ability of wild-type SopB and SopB-K6R to induce Akt
phosphorylation. HeLa cells were infected with DsopB-
sigE bacteria, complemented with either pWSKDE-GSK
or pWSKDE-K6R-GSK. At various times p.i., cells were
lysed and subject to immunoblotting with antibodies
against phospho-GSK (translocated SopB), GSK tag (total
SopB), phospho-Ser473-Akt (activated Akt) and Akt pan
(total Akt) (Fig. 7A). Like for wild-type SopB, translocated
SopB-K6R accumulated with time in epithelial cells,
although only the 60 kDa, unmodiﬁed, species was de-
tected. The total amount of SopB-K6R displayed a similar
trend with time. The Akt activation kinetics induced by the
two bacterial strains were similar, with a peak of Ser473-
phospho-Akt at 1 h p.i. However, infection with bacteria
expressing the SopB-K6R mutant caused a threefold to
ﬁvefold increase in the peak intensity of phospho-Akt sig-
nal, as well as sustainedAkt phosphorylation up to 4 h p.i.
Akt activation is a multistep process that involves
recruitment from the cytosol to the plasma membrane
where phosphorylation on Ser473 and Thr308 residues is
followed by release of the now active kinase into the
cytosol where it can target a variety of substrates (Franke,
2008). Recently, it has also been shown that Akt can also
be activated on a subset of endosomes (Schenck et al.,
2008).As SopB is an inositol phosphatase that affects the
concentration of membrane phospholipids, we next used
confocal microscopy to assess whether SopB-K6R affects
the levels of phosphorylated Akt on membranes. HeLa
cells expressing EGFP-mAkt1 were infected with DsopB-
sigE bacteria, or DsopB-sigE bacteria complemented with
pWSKDE or pWSKDE-K6R. The DsopB-sigE mutant was
used as a negative control because it does not induce Akt
phosphorylation (Steele-Mortimer et al., 2000). At various
times up to 90 min p.i., cells were ﬁxed and processed for
immunoﬂuorescence staining. Before permeabilization,
cells were incubated with ﬂuorescently conjugated wheat
germ agglutinin (WGA) to label the plasma membrane.
Subsequently, monolayers were permeabilized and
immunostained using anti-phospho-Ser473-Akt antibod-
ies. Plasma membrane ruffles, which are induced by Sal-
monella at the site of invasion and persist after bacterial
internalization (Kubori and Galan, 2003), were identiﬁed
using spinning disc confocal microscopy and single
optical sections were acquired in the far-red (WGA,
plasma membrane), green (EGFP-Akt) and red (phospho-
Akt) channels. Subsequently the ruffle was selected by
thresholding on the WGA-Alexa Fluor® 647 channel. The
ratio of the average pixel intensity for the phospho-
Ser473-Akt signal to EGFP-Akt ﬂuorescence (RpAkt/Akt)
was subsequently determined for each ruffle (Fig. 7B).
In this microscopy-based assay, RpAkt/Akt for DsopB-sigE
Fig. 6. Ubiquitination of SopB is not required for early SCV trafficking events.
A. HeLa cells expressing 2xFYVE-EGFP were infected with wild-type, DsopB-sigE, DsopB-sigE complemented with plasmid-borne SopB and
SigE (pWSKDE) or plasmid-borne SopB-K
6R mutant and SigE (pWSKDE-K
6R). At the indicated times, monolayers were ﬁxed and
immunostained with anti-Salmonella LPS antibodies to differentiate intracellular and extracellular bacteria. The number of intracellular bacteria
positive for 2xFYVE-EGFP, a probe for PI(3)P, was scored visually by ﬂuorescence microscopy. Means  SD from three separate experiments
are shown (n  145 bacteria for each condition). Asterisk denotes signiﬁcantly different from wild-type bacteria (P < 0.001, analysis of variance
(ANOVA) with Dunnett’s post hoc test).
B. HeLa cells were infected with Salmonella as described for (A) and at the indicated times monolayers were ﬁxed and immunostained with
rabbit polyclonal anti-Salmonella LPS antibodies and mouse monoclonal anti-human LAMP1 antibodies. The number of Salmonella positive for
LAMP1 staining was scored visually by ﬂuorescence microscopy. Means  SD from three separate experiments are shown (n > 300 bacteria
for each condition). Asterisk denotes signiﬁcantly different from wild-type bacteria (P < 0.02, ANOVA with Dunnett’s post hoc test).
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with bacteria complemented with plasmid-borne SopB
resulted in Akt phosphorylation at the plasma membrane,
as indicated by RpAkt/Akt values > 1. Infection with bacteria
expressing SopB-K6R also caused the accumulation of
phospho-Akt in plasma membrane ruffles, at levels com-
parable to wild-type SopB at 30 min p.i., but at signiﬁ-
cantly greater levels at 60 and 90 min p.i. (Fig. 7B). These
differences were not attributable to changes in the amount
of EGFP-Akt recruited to plasma membrane ruffles
(results not shown). Notably, we never detected EGFP-
Akt or activated Akt on the SCV over the studied time-
course (results now shown). This microscopy datum
concurs with the immunoblot data from whole cell lysates
(Fig. 7A) and together these experiments demonstrate
that ubiquitination of SopB regulates its biological activity
at the plasma membrane, where it mediates phosphory-
lation of Akt.
Discussion
Here we have studied the contribution of ubiquitination to
the Salmonella virulence factor, SopB, a type III effector
that is essential for Akt activation at the site of bacterial
entry into host epithelial cells. Using a combination of
mass spectrometry and site-directed mutagenesis, we
have shown that at least six of the 50 lysine residues
in SopB are sites of ubiquitination, speciﬁcally mono-
ubiquitination. Of the six modiﬁed lysine residues, ﬁve are
clustered at the N-terminus of SopB and one is at the
C-terminus. While a three-dimensional structure of SopB
is not yet available, we predict that these residues are
exposed on the surface of SopB, because ubiquitin is
preferentially added to lysines present in surface-exposed
loops (Catic et al., 2004). Recently, two other groups have
also reported ubiquitin conjugation sites of SopB. Rogers
et al. identiﬁed two of the same residues (Lys19 and
Lys541), although this was not conﬁrmed by mutagenesis
(Rogers et al., 2008). Patel et al. identiﬁed two ubiquiti-
nated tryptic peptides of SopB by mass spectrometry and
subsequently mutated nine lysines at the amino terminus
of SopB to demonstrate that all of these residues can be
modiﬁed. Individual substitution of the identiﬁed lysine
residues had little effect on SopB ubiquitination and muta-
tion of all identiﬁed residues reduced, but did not eliminate,
ubiquitination (this manuscript and Patel et al., 2009).
Such redundancy of ubiquitin attachment sites is well
documented for numerous mammalian proteins (Hou
et al., 1994; Marotti et al., 2002; Lee et al., 2004; Huang
et al., 2006; Meray and Lansbury, 2007). Furthermore,
mutation of target lysine residues sometimes can lead to
the modiﬁcation of lysine residues that do not normally
participate as ubiquitination sites (Hou et al., 1994; Marotti
et al., 2002).This promiscuity of ubiquitin conjugation sites
and the fact that only a fraction of the protein is modiﬁed
deﬁne some of the challenges faced in addressing the
biochemical aspects of protein ubiquitination.
Salmonella enterica serovars differ greatly in their host
speciﬁcity and the type of disease they cause. Some of
these serovars are highly host adapted, including Galli-
narum, which only infects birds, and Typhi, only higher
primates, whereas others such as Typhimurium have a
broad host range. Likewise, the repertoire of type III effec-
tors is not the same for all these serovars. For example,
effectors encoded by phages or phage remnants, includ-
ing AvrA, SopE, SspH1 and SseI, are absent from many
serovars (Tsolis et al., 1999; Prager et al., 2000; Hansen-
Wester et al., 2002; Rahman et al., 2005). By contrast,
SopB appears to be prevalent (Prager et al., 2000; Mirold
et al., 2001; Streckel et al., 2004; Rahman, 2006). The
deduced amino acid sequence for full-length SopB
is available for the following S. enterica serovars in
GenBank; serovar Agona (GenBank accession number
YP_002145960),serovarCholeraesuis(AAC33723),sero-
var Dublin (AAC33723), serovar Enteriditis (CAR32537),
serovar Gallinarum (CAR36869), serovar Hadar
(EDZ33941), serovar Heidelberg (YP_002045092),
serovar Javiana (EDZ05526), serovar Kentucky
(EDZ19176), serovar Newport (YP_002040347), serovar
Saintpaul (EDZ10612), serovar Schwarzengrund
(YP_002114089), serovar Typhi (NP_455588), serovar
Virchow (ZP_03216329) and serovar Weltevreden
(EDZ28428). Interestingly, all six identiﬁed ubiquitin con-
jugation sites (Lys13, Lys19, Lys23, Lys37, Lys41 and
Fig. 7. Ubiquitination of SopB downmodulates its activity at the plasma membrane.
A. HeLa cells were infected with DsopB-sigE Salmonella complemented with either pWSKDE-GSK or pWSKDE-K
6R-GSK. At the indicated
times, monolayers were solubilized and proteins subject to immunoblotting with antibodies against phospho-GSK (translocated SopB), GSK
tag (total SopB), phospho-Ser473-Akt (activated Akt) and Akt pan (total Akt).
B. HeLa cells expressing EGFP-mAkt were infected with DsopB-sigE Salmonella (DB), or DsopB-sigE Salmonella complemented with
pWSKDE (SopB) or pWSKDE-K
6R( K
6R). Monolayers were ﬁxed, incubated with Alexa Fluor
®647-conjugated WGA to label the plasma
membrane, permeabilized and immunostained with anti-phospho-Ser473-Akt antibodies. Single optical sections through individual ruffles were
acquired with a spinning disk confocal microscope. Regions of interest were selected by thresholding on the WGA image and transferred to
the EGFP-mAkt and phospho-Ser473-Akt images. The ratio of mean ﬂuorescence intensity for phospho-Akt : total Akt was subsequently
determined. Each data point represents one ruffle. Data with means from three independent experiments are shown (n  55 ruffles for each
condition). P-values were determined by Student’s t-test.
C. Representative confocal microscopy images from (B) at 60 min p.i. Arrowheads indicate Salmonella-induced membrane ruffles. Scale bar is
10 mM.
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conservation implies that SopB and its ubiquitination are
required for pathogenesis irrespective of host or serovar
differences. Two of these lysine residues, Lys19 and
Lys41, are also conserved in the SopB homologue from
Shigella, IpgD (Allaoui et al., 1993; Hong and Miller,
1998), although whether IpgD is ubiquitinated remains to
be determined.
SopB is an inositol phosphatase that can hydrolyse a
number of inositol phosphates and phosphoinositides in
vitro (Marcus et al., 2001). Interestingly, ubiquitination is
known to regulate the activity of some mammalian inositol
phosphatases. For example, the E3 ubiquitin ligase
NEDD4-1, poly-ubiquitinates PTEN (phosphatase and
tensin homologue deleted on chromosome 10), an inositol
3′-phosphatase that is a central negative regulator of
phosphatidylinositol 3-kinase (PI3K) signalling, leading to
its proteasomal degradation and thereby limiting its
actions on phosphatidylinositol (3,4,5)-trisphosphate at
the plasma membrane (Wang et al., 2007). NEDD4-1 also
mono-ubiquitinates PTEN, inducing its translocation to
the nucleus (Trotman et al., 2007). Therefore, ubiquitina-
tion of PTEN controls both its cellular localization and
stability. Another inositol 3′-phosphatase, myotubularin-
related protein 4, localizes to endosomes and is also
poly-ubiquitinated by NEDD4, although the role of this
post-translational modiﬁcation is unknown (Plant et al.,
2009). It might prove that ubiquitin-mediated control of
inositol phosphatase function is more widespread than
currently appreciated.
Upon bacterial contact with host cells, SopB is deliv-
ered to the cytoplasmic surface of the plasma membrane
where it participates in plasma membrane ruffling and
signalling events, and after bacterial entry it continues to
be translocated for many hours, localizing to the SCV.
Here we have shown that one role of SopB ubiquitination
is to downregulate its activity at the plasma membrane.
This concurs with the recent results of others (Patel et al.,
2009). While this might be an indirect effect attributable to
mutagenesis-induced changes in SopB enzymatic acti-
vity, it seems much more likely that it is directly due
to ubiquitin-dependent changes in localization. Patel
et al. (2009) have shown using an invasion-defective,
translocation-competent Salmonella strain, that while
SopB is internalized from the plasma membrane into
endocytic compartments, ubiquitin-defective SopB is
retained at the plasma membrane. Ubiquitin, primarily
mono-ubiquitin, is well known to function as an internal-
ization signal for eukaryotic plasma membrane proteins
(Mukhopadhyay and Riezman, 2007), but this is the ﬁrst
example for a bacterial virulence protein. Ubiquitination of
some plasma membrane receptors controls the amplitude
and kinetics of signalling resulting from their engage-
ment (Marmor and Yarden, 2004). Upon growth factor
stimulation, these transmembrane proteins are mono-
ubiquitinated, driving their internalization and sorting them
to the endosomal/lysosomal pathway (Haglund et al.,
2003; Staub and Rotin, 2006). While ubiquitin-deﬁcient
plasma membrane receptors are internalized normally,
their turnover by lysosomal degradation is delayed, but
not prevented (Huang et al., 2006). This leads to
increased and prolonged PI3K/Akt signalling in the case
of granulocyte colony-stimulating factor receptor (Ai et al.,
2008). Conversely, overexpression of the E3 ubiquitin
ligase cbl-b enhances ubiquitination of the epidermal
growth factor receptor, shortening the duration of its sig-
nalling (Ettenberg et al., 1999). It is important to note that
ubiquitination of plasma membrane receptors does not
lead to an all-or-nothing effect, but rather modulates the
intensity and duration of signalling events, serving a ‘ﬁne-
tuning’ role. Ubiquitin-mediated downregulation of signal-
ling is not limited to transmembrane receptors at the
plasma membrane because we, and others (Patel et al.,
2009), observe a similar phenotype for SopB-dependent
signalling.
While SopB is translocated by T3SS1 immediately upon
contact with host cells, we did not detect modiﬁcation of
translocated SopB until  1 h p.i. The onset of SopB
ubiquitination is coincident with the peak of Akt phospho-
rylation and leads to the efficient downmodulation of Akt
activation at the plasma membrane. By contrast, we found
no evidence for SopB ubiquitination being involved in
SCV biogenesis. Unlike Akt activation, Rab5 and LAMP1
recruitment to the SCV and PI(3)P formation are affected,
but not absolutely dependent, on SopB. SCV acquisition
defects are only observed  40 min p.i. for a sopB dele-
tion mutant (this manuscript and Mallo et al., 2008), and
thereafter SCV maturation is indistinguishable from wild-
type bacteria. The lack of inﬂuence of SopB ubiquitination
on SCV trafficking is seemingly in agreement with the time
frame of SopB-dependence ( 40 min p.i.) and kinetics of
SopB modiﬁcation ( 1 h p.i.). However, others have
reported that Salmonella expressing ubiquitin-deﬁcient
SopB are defective for Rab5 recruitment to the SCV at
10–20 min p.i. SopB phosphatase activity is required for
the presence of active Rab5 on the SCV, which recruits
the PI3K Vps34, leading to PI(3)P production on the SCV
(Mallo et al., 2008). It is difficult to reconcile how Rab5
recruitment can be affected by SopB ubiquitination (Patel
et al., 2009), but not PI(3)P production (this study) and
further studies are required to resolve this discrepancy.
Ubiquitination can alter protein location (Schnell and
Hicke, 2003). While SopB remains peripherally bound to
membranes via hydrophobic interactions regardless of its
ubiquitination status (this report and Patel et al., 2009),
we have shown that ubiquitination is required for the per-
sistence of SopB on the SCV. Analogous to this, the
association of many yeast and mammalian proteins with
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cytic machinery is largely controlled by their mono-
ubiquitination (Raiborg et al., 2003). With less SopB being
present on the SCV, this might explain the intracellular
replication defect of bacteria expressing ubiquitin-
defective SopB (Patel et al., 2009). However, another late
event know to be affected by SopB, SCV positioning
(Wasylnka et al., 2008), does not appear to depend upon
ubiquitination (our unpublished results). Given that trans-
located SopB persists for many hours on the SCV, we
believe that additional SopB-dependent functions will be
discovered. Identiﬁcation of the E3 ubiquitin ligase that
targets SopB and protein binding partners of ubiquitinated
SopB are key to clarifying the contribution of ubiquitination
to activity and/or localization of this Salmonella effector.
Experimental procedures
Bacterial strains and plasmids
The wild-type strain S. enterica serovar Typhimurium SL1344
(Hoiseth and Stocker, 1981) and the DsopB-sigE mutant (Knodler
et al., 2006) were as previously described.
To construct the complementing plasmid, pWSKDE (see
Table S1 for a list of plasmids used in this study), the sopB-sigE
open reading frames and approximately 400 bp of upstream
region was ampliﬁed from pACDE (Marcus et al., 2001) with the
oligonucleotides SigD-Hind-F and SigD-Nhe-R with the Expand
High Fidelity PCR System (Roche) (see Table S2 for all oligo-
nucleotide sequences used in this study). The resulting amplicon
was digested with HindIII/NheI and ligated into HindIII/XbaI-
digested pWSK29 (Wang and Kushner, 1991). The pWSKDE-
K
6R mutant (K13R K19R K23R K37R K41R K541R mutations)
was generated by site-directed mutagenesis with the
Quikchange kit (Stratagene).
To monitor the translocation of SopB by immunoblotting, a
13-residue tag derived from human GSK was fused to the
C-terminus of SopB by overlap extension PCR. sopB and
approximately 400 bp of upstream region was ampliﬁed from
pWSKDE with the oligonucleotides SigD-Hind-F and SigD-
GSK-R. The sopB-sigE intergenic region and sigE were ampliﬁed
from pWSKDE with the oligonucleotides SigD-GSK-F and SigD-
Nhe-R. After a second round of PCR with a mix of these two
amplicons and the oligonucleotides SigD-Hind-F and SigD-
Nhe-R, the product was digested with HindIII/NheI and ligated
into HindIII/XbaI-digested pWSK29 to create pWSKDE-GSK.
Similarly, pWSKDE-K
6R was used as a template for ampliﬁcation
to create pWSKDE-K
6R-GSK.
To detect translocated SopB by immunoﬂuorescence, tandem
HA tags were fused to the C-terminus of SopB by overlap exten-
sion PCR. pWSKDE or pWSKDE-K
6R served as templates with
the oligonucleotide pairs SigD-Hind-F and SigD-2HA-R and
SigD-HA-F and SigD-Nhe-R for the initial PCR ampliﬁcations.
Secondary PCR reactions and cloning were as described above,
generating pWSKDE-2HA and pWSKDE-K
6R-2HA.
For ectopic expression in mammalian cells, sopB was ampli-
ﬁed from S. Typhimurium SL1344 genomic DNA with the oligo-
nucleotides Myc-SigD-F and pGAD-SigD-R. The amplicon was
digested with EcoRI and BglII and ligated into the corresponding
sites of pCMV-Myc (Clontech) to create pCMV-Myc-SopB.
pCMV-Myc-SopB K6R was generated with the QuikChange site-
directed mutagenesis kit (Stratagene).
For ectopic expression of EGFP-tagged Akt, the open reading
frame of murine Akt1 was ampliﬁed from GFP-HA-Akt (Watton
and Downward, 1999) with the oligonucleotides EGFP-mAkt1-F
and EGFP-mAkt1-R. The amplicon was digested with BglII/SalI
and ligated into the corresponding sites of pEGFP-C1 (Clontech)
to create EGFP-mAkt1. The plasmid encoding for 2xFYVE-EGFP
was a gift from Mark Jepson (Pattni et al., 2001).
Plasmids encoding for HA-tagged ubiquitin (Lim et al., 2005)
and Ubl modiﬁers, ISG15 (Kim et al., 2004), NEDD8 (Kamitani
et al., 1997) and SUMO1 (Kamitani et al., 1998) were purchased
from Addgene (Addgene plasmids 17608, 12444, 18711 and
17359 respectively).
All plasmid sequences were veriﬁed by DNA sequencing.
Generation of polyclonal SopB antibodies
Murine polyclonal antibodies against SopB were prepared as
described (Lacy and Voss, 1986), with some modiﬁcations.
Female BALB/c mice (Jackson Laboratory) were inoculated sub-
cutaneously at two sites with 8 mg puriﬁed recombinant SopB
(kindly provided by Dr Sandra Marcus) in 0.2 ml Ribi Adjuvant
(GlaxoSmithKline). Mice were boosted after 2 weeks with
another 8 mg SopB resuspended in RibiAdjuvant.Asecond boost
was prepared in Complete Freund’s Adjuvant (Sigma-Aldrich)
because Ribi Adjuvant was no longer commercially available.
Mice were bled and titres checked by immunoblot blot using
recombinant SopB. Mice were given two doses of 0.5 ml pristine
by intraperitoneal injection 1 week apart followed 1 week later by
5 ¥ 10
6 SP2 cells i.p. in 0.5 ml Hank’s balanced salt solution
(HBSS, Mediatech). Mice developed ascites 3 weeks later and
ascites ﬂuid was collected over 3 days, pooled and stored at
-20°C. This immunization protocol was approved by the Rocky
Mountain Laboratories Animal Care and Use Committee.
Bacterial infection of mammalian cells
HeLa adenocarcinoma epithelial cells (ATCC CCL-2) were grown
in Eagle’s modiﬁed medium (Mediatech) containing 10% (v/v)
heat-inactivated fetal calf serum (Invitrogen) at 37°C with 5%
CO2. Cells seeded in 6 well plates, or on glass coverslips in
24 well plates, were infected 18–24 h after seeding with S. Typhi-
murium grown under invasion optimizing conditions (Knodler
et al., 2006). Cells were serum-starved for 3 h prior to infection
and maintained in serum-free media for the entire infection,
unless otherwise indicated. Bacteria were added to HeLa cells at
a MOI of ~50 and invasion allowed to proceed at 37°C for 10 min.
Monolayers were washed three times in HBSS, chased for
20 min in antibiotic-free serum-free media and then incubated in
serum-free growth media containing 50 mgm l
-1 gentamicin for
1 h, followed by 10 mgm l
-1 gentamicin for the remainder of the
experiment.
Inhibitor experiments
To stop bacterial protein synthesis after bacterial internalization,
10 mgm l -1 tetracycline (Sigma) was added to the growth medium.
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shown). For Fig. 1B, tetracycline was added at 30 min p.i. For
SopB stability experiments (Fig. 3B), tetracycline was added at
2 h p.i. To prevent bacterial transcription (Fig. 1C), 5 mgm l
-1
rifampicin (Sigma) was added to the growth medium after the
initial 10 min infection and maintained throughout.
Taqman® real-time PCR analysis
HeLa cells were seeded in 6 well plates the day prior to infection
(2 ¥ 10
5 cells/well) and infected with 5 ml invasive Salmonella
(MOI ~50) as described above. Bacterial and mammalian RNA
and DNA were extracted from infected monolayers using TRIzol
®
(Invitrogen) as described previously (Drecktrah et al., 2006).
Brieﬂy, DNA was removed from the RNA fraction by treating with
DNase I (Invitrogen) according to the manufacturer’s instructions.
cDNAwas synthesized using 2 mg RNAand the Taqman
® reverse
transcription reagent kit (Applied Biosystems) according to the
manufacturer’s instructions. Primers and probes were designed
using Primer Express
® version 1.5 (Applied Biosystems). Real-
time PCR was performed in 384 well plates using a 7900 HT
Sequence Detection System (Applied Biosystems) with primers
and probes for sopB and ssaH (Drecktrah et al., 2006) and ftsZ.
The amount of sopB and ssaH cDNA was normalized to ftsZ
cDNA for each time point and condition.
Subcellular fractionation and membrane extractions
Fractionation of infected host cells was as described previously
(Knodler et al., 2003), with the following modiﬁcations. Four
10 cm dishes of HeLa cells were infected with 50 ml invasive
Salmonella as described above. At 1.5 h p.i., cells were collected
by scraping and then mechanically disrupted by passing through
a 22-gauge needle. To one half of the sample, 5 ml cold homo-
genization buffer, containing protease inhibitor cocktail set III and
phosphatase inhibitor cocktail set II (EMD Biosciences), was
added. Nuclei were pelleted by centrifugation at 1000 g for 5 min
at 4°C (P1K). The supernatant was harvested and centrifuged
again at 6000 g, 4°C, to pellet bacteria (P6K). Both pellets were
resuspended in 300 ml boiling 1.5¥ SDS-PAGE buffer. The other
half was centrifuged at 6000 g for 10 min at 4°C, the supernatant
collected and ultracentrifuged at 100 000 g for 30 min at 4°C to
separate membranes (P100K) from cytosol (S100K). Boiling 6¥
SDS-PAGE sample buffer was added to the supernatant and the
pellet was resuspended in 300 ml boiling 1.5¥ SDS-PAGE buffer.
Equal volumes of each fraction were loaded onto SDS-PAGE
gels and subject to immunoblotting.
For membrane extraction studies, HeLa cells in 10 cm dishes
were infected with Salmonella as above. At 1.5 h p.i., cells were
mechanically disrupted in 300 ml cold homogenization buffer con-
taining protease inhibitor cocktail set III and phosphatase inhibi-
tor cocktail set II (EMD Biosciences) and centrifuged at 6000 g
for 10 min at 4°C. The supernatant was collected and divided into
four aliquots. Samples were ultracentrifuged at 50 000 g for
30 min at 4°C to pellet host cell membranes. Membranes were
resuspended in 150 ml phosphate-buffered saline (PBS), 1 M
NaCl, 0.1 M Na2CO3 pH 11.5 or 1% TX-100. After 30 min incu-
bation on ice, samples were ultracentrifuged at 100 000 g, 4°C,
for 30 min. Boiling 6¥ SDS-PAGE sample buffer (50 ml) was
added to supernatants. Membranes were resuspended in 150 ml
each respective extraction buffer and 50 ml boiling 6¥ SDS-PAGE
sample buffer added. Equal volumes were loaded onto SDS-
PAGE gels and subject to immunoblotting.
Transient transfection of mammalian cells
HeLa cells were seeded in 10 cm dishes, 6 well plates or on glass
coverslips in 24 well tissue culture plate(s) 6–8 h prior to trans-
fection. Plasmid DNA was prepared using the Perfectprep
Plasmid Midi kit (Eppendorf) according to the manufacturer’s
instructions and cells transfected with FuGENE® 6 reagent
(Roche). Cells were lysed 18–20 h post transfection in 150 ml
boiling 1.5¥ SDS-PAGE sample buffer for immunoblotting (6 well
plates) or processed for immunoprecipitation (10 cm dishes) or
immunoﬂuorescence (glass coverslips in 24 well plates) as
described below.
Immunoprecipitation and mass spectrometry
Twelve 10 cm dishes of HeLa cells were transfected with pCMV-
Myc-SopB as described above and incubated for 18 h in Eagle’s
modiﬁed medium containing fetal calf serum. Monolayers were
then washed twice in ice-cold PBS and collected by scraping into
PBS. After centrifugation at 1000 g for 10 min at 4°C, cells were
lysed on ice for 20 min in 1.8 ml of 50 mM Tris-HCl pH 8.0,
150 mM NaCl, 0.5% TX-100, 1 mM EDTA containing protease
inhibitor cocktail set III and phosphatase inhibitor cocktail set II
(EMD Biosciences). Lysates were clariﬁed by centrifugation at
5000 g for 15 min at 4°C. The supernatant was pre-cleared by
incubation with 35 ml Protein A Sepharose (Amersham) for 1 h at
4°C and then incubated for 2 h with 10 ml anti-Myc antibody
(9B11; Cell Signalling Technology). Immune complexes were col-
lected with 35 ml Protein A Sepharose for 2 h at 4°C. Sepharose
beads were washed four times in lysis buffer and once in lysis
buffer without TX-100, and bound proteins were eluted by boiling
in 1.5¥ SDS-PAGE sample buffer for 5 min. Proteins were sepa-
rated by SDS-PAGE on 10% polyacrylamide gels (Bio-Rad) and
visualized by GelCode Blue staining (Pierce). Analysis of ubi-
quitin conjugation sites was carried out at the Taplin Mass Spec-
trometry Facility, Harvard Medical School.
For co-immunoprecipitation experiments, three 10 cm dishes
were transfected with plasmids encoding HA-tagged ubiquitin or
HA-tagged Ubl modiﬁers and infected 18–20 h later with Salmo-
nella at a moi ~150 for 10 min. Cells were not serum-starved in
these experiments. At 2 h p.i., cells were collected by scraping
into cold PBS and lysed on ice for 15 min in 20 mM Tris-HCl
pH 8.0, 150 mM NaCl, 1% TX-100, 1 mM EDTA containing pro-
tease inhibitor cocktail set III and phosphatase inhibitor cocktail
set II (EMD Biosciences). Samples were centrifuged at 6000 g for
10 min, the supernatant collected and SopB immunoprecipitated
with 1 mg rabbit polyclonal anti-SopB antibodies as described
previously (Marcus et al., 2002).
Immunoﬂuorescence staining
HeLa cells seeded on glass coverslips were ﬁxed in 2.5% (w/v)
paraformaldehyde (PFA) for 10 min at 37°C, then permeabilized
with 0.1% (w/v) saponin in 10% normal goat serum (NGS, Invit-
rogen) (NGS-saponin) in PBS or 10% normal donkey serum
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stained as described (Knodler et al., 2003). Primary antibodies
were: rabbit polyclonal anti-Salmonella LPS (1:2000 dilution,
Difco) and mouse monoclonal antihuman LAMP1 (H4A3, 1:1500
dilution, Developmental Studies Hybridoma Bank) for LAMP1
recruitment analysis; or goat polyclonal anti-Salmonella (CSA-1,
1:1000 dilution, KPL) and mouse monoclonal anti HA.11 (clone
16B12, 1:1000 dilution, Covance) for immunolocalization of
SopB-2HA. For 2xFYVE-EGFP recruitment to the SCV, extra-
cellular and intracellular bacteria were distinguished by immuno-
staining as described previously (Celli et al., 2001). Extracellular
bacteria were immunostained with mouse anti-Salmonella LPS
antibodies (1:5000, clone 1E6, Biodesign International) prior to
permeabilization and all bacteria were stained with rabbit
anti-Salmonella LPS antibodies (1:2000, Difco) postpermeabili-
zation. Only intracellular bacteria were scored for 2xFYVE colo-
calization. All Alexa Fluor
® secondary antibodies were from
Invitrogen and used at 1:800 dilution. Samples were observed on
a Nikon Eclipse E800 or TE2000 epiﬂuorescence microscope
equipped with a Plan Apo 60¥/1.4 objective for quantitative
analysis.
Confocal images were captured on a Carl Zeiss LSM 510 Meta
confocal laser-scanning microscope. Confocal sections of 0.3 mm
and image sizes of 1024 ¥ 1024 pixels (for SopB-2HA, Fig. 5C)
or 512 ¥ 512 pixels (for EGFP-mAkt recruitment, Fig. 7C) were
acquired. Image analysis and maximum intensity projections
were performed with ImageJ v.1.4.1 (written by Wayne Rasband
at the US National Institutes of Health and available at http://
rsbweb.nih.gov/ij/download.html) and ﬁgures assembled using
Adobe Photoshop CS2.
Analysis of Akt recruitment to membrane ruffles
For recruitment of Akt to Salmonella-induced membrane ruffles,
cells seeded on glass coverslips were transfected overnight with
EGFP-mAkt1, infected with Salmonella and at the indicated
times, monolayers were ﬁxed in PFA as described above.
Monolayers were incubated with 1 mg ml-1 Alexa Fluor®647-
conjugated WGA(Invitrogen) in PBS for 5 min to label the plasma
membrane, ﬁxed for 5 min in 2.5% w/v PFA at room temperature,
washed, permeabilized with NGS-saponin and immunostained
with mouse monoclonal anti-Ser473-phospho-Akt antibodies
(1:200 dilution, 587F11, Cell Signaling Technology) followed by
Alexa Fluor
®568-labelled goat anti-mouse IgG (Invitrogen). Con-
focal images were acquired on an Ti-E inverted microscope with
a6 0¥ 1.4 NAobjective (Nikon Instruments), ﬁtted with a Nipkow-
spinning disk (Perkin-Elmer), a custom solid state laser launch
with 488 nm, 561 nm and 643 nm laser lines (Prairie Technolo-
gies), emission ﬁlters of 525/50, 600/45 and 700/75 nm (Chroma
Technologies) in a high speed ﬁlter wheel controlled by a Sutter
10-2 ﬁlter wheel controller (Sutter Instruments), a Cascade II:512
EM-CCD camera (Photometrics) and controlled by Metamorph
7.6.0 (Molecular Devices). Laser light intensities and capture
settings were kept constant throughout the experiment. Only
cells with low EGFP expression levels were selected for analysis.
Plasma membrane ruffles were selected from a plane above the
main cell body by thresholding on the WGA channel. The result-
ing region of interest was transferred to the EGFP-Akt and
phospho-Ser473-Akt images and the ratio of mean ﬂuorescent
intensity for phospho-Ser473-Akt : EGFP-Akt in the membrane
ruffle determined.
Immunoblotting
Proteins were separated by SDS-PAGE, transferred to nitrocel-
lulose (Bio-Rad) and blocked in Tris-buffered saline containing
5% non-fat dried milk powder (TBST-milk) or 5% bovine serum
albumin (TBST-BSA) for 1 h at room temperature. Blots were
incubated overnight at 4°C with the following primary antibodies:
rabbit anti-phospho-GSK-3b Ser9 (Cell Signaling Technology)
1:2000 dilution in TBST-BSA, rabbit anti-GSK-3b-tag (Cell
Signaling Technology) 1:5000 dilution in TBST-BSA, rabbit
monoclonal anti-phospho-Ser473-Akt (193H12, Cell Signaling
Technology) 1:10 000 dilution in TBST-BSA, rabbit monoclonal
anti-Akt pan (11E7, Cell Signaling Technology) 1:2000 in TBST-
BSA, mouse monoclonal anti-HA.11 puriﬁed (16B12, Covance)
1:20 000 in TBST-milk, mouse polyclonal anti-SopB 1:2000 in
TBST-milk, rabbit anti-calnexin (Stressgen) 1:40 000 in TBST-
milk, rabbit anti-calreticulin (Affinity Bioreagents) 1:10 000 in
TBST-milk, rabbit anti-lamin A/C (Cell Signaling Technology)
1:5000 in TBST-milk, mouse anti-Hsp27 (G31, Cell Signaling
Technology) 1:10 000 in TBST-milk, mouse anti-LAMP1 (H4A3,
Developmental Studies Hybridoma Bank) 1:5000 in TBST-milk,
mouse anti-DnaK (8E2/2, Stressgen) 1:40 000 in TBST-milk.
Immunoblotting with rabbit polyclonal anti-SopB antibodies
was as described previously (Knodler et al., 2006). Blots were
washed in TBST or TBST-milk, incubated with affinity puriﬁed
HRP-conjugated goat anti-rabbit or horse anti-mouse IgG (Cell
Signaling Technology) 1:20 000 in TBST-milk for 1 h, washed and
developed using enhanced chemiluminescence according to the
manufacturer’s directions (SuperSignal West Femto Maximum
Sensitivity substrate, Thermo Scientiﬁc).
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